|  |  |  |  |  |
| Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
| Item | Cyfra ELISA Assay | Anti-Adalimumab (Humira®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | GPIHBP1 Autoantibody ELISA | Tenascin-C Large (FN III-B) ELISA Assay |
| Citations | | | | | |
| Catalog Number | 211-10 | TM09009 | TM09036 | 27267 | 27767 |
| Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
| Description | Solid phase, non-competitive immunoassay (ELISA) for the determination of soluble cytokeratin 19 fragments in human serum. 510(k) cleared, can be used in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Adalimumab (Humira®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Indirect ELISA for the determination of human GPIHBP1 Autoantibody in serum, EDTA-plasma, heparin plasma, and post-heparin EDTA-plasma. For research use only, not for use in diagnostic procedures. | Solid phase sandwich ELISA for the determination of Tenascin-C high molecular weight variants including FNâ…¢-B domain in serum, EDTA Plasma, and cell culture supernatant of human, mouse and rat. For research use only, not for use in diagnostic procedures. |
| Detection Target | Adrenaline / Noradrenaline / Dopamine | PSA (Total) | sAPP Total | Progesterone | CCPlus: Anti-Cyclic Citrullinated |
| Sample Type | Multiple | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Serum | Serum |
| Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) |
| Detection Range | 1.4 to 47.6 ng/mL | 0 / 5 - 150 ng/mL | Anti-Ustekinumab (Stelara®) | 0 / 0.008 - 0.50 U/mL | 0.20 to 12.5 ng/mL |
| Sensitivity | Adrenaline: 0.25 ng/mL x C*; Noradrenaline: 0.1 ng/mL x C*; Dopamine 0.25 ng/mL x C*. Sensitivity based on calculated correction factor. | Inquire | 0.06 ng/mL | 0.05 ng/mL | 0.7 |
| Assay Time | 1 hr 45 mins (incubation) | 2 hours, 15 min. total incubation time. | 2 hour, 30 min. total incubation time. | 2 hour total incubation time. | 2 hrs (incubation) |
| Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |